Canadian Online Pharmacy

CDER New September 23, 2014

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

September 22, 2014


New and Generic Drug Approvals

September 20, 2014

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Ceftin  cefuroxime axetil Tablet;Oral Glaxosmithkline Labeling Revision
Ceftin cefuroxime axetil For Suspension;Oral Glaxosmithkline Labeling Revision

September 19, 2014

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Ammonia N 13 Injection ammonia n 13 injection Injectable;Injection Shertech Labs Llc Approval
Chantix varenicline tartrate Tablet;Oral Pfizer Inc Efficacy Supplement with Clinical Data to Support
Chantix varenicline tartrate Tablet;Oral Pfizer Inc Labeling Revision
Janumet Xr metformin hydrochloride; sitagliptin phosphate Tablet, Extended Release;Oral Merck Sharp Dohme Manufacturing Change or Addition
Lexiscan regadenoson Solution;Intravenous Astellas Labeling Revision
Lumigan bimatoprost Solution/Drops;Ophthalmic Allergan Manufacturing Change or Addition
Marcaine bupivacaine hydrochloride Injectable;Spinal Hospira Manufacturing Change or Addition
Marcaine Hydrochloride bupivacaine hydrochloride Injectable;Injection Hospira Manufacturing Change or Addition
Marcaine Hydrochloride Preservative Free bupivacaine hydrochloride Injectable;Injection Hospira Manufacturing Change or Addition
Marcaine Hydrochloride W/ Epinephrine bupivacaine hydrochloride; epinephrine bitartrate Injectable;Injection Hospira Manufacturing Change or Addition
Marcaine Hydrochloride W/ Epinephrine Preservative Free bupivacaine hydrochloride; epinephrine bitartrate Injectable;Injection Hospira Manufacturing Change or Addition
Nasacort Allergy 24 Hour triamcinolone acetonide Spray, Metered;Nasal Sanofi Aventis Us Labeling Revision
Otezla apremilast Tablet;Oral Celgene Corp Manufacturing Change or Addition
Pentostatin pentostatin Injectable;Injection Mylan Institutional Approval
Rizatriptan Benzoate rizatriptan benzoate Tablet, Orally Disintegrating;Oral Macleods Pharms Ltd Approval
Temodar temozolomide Capsule;Oral Merck Sharp Dohme Manufacturing Change or Addition

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery